These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 20329436)

  • 1. Pazufloxacin.
    Vora A
    J Assoc Physicians India; 2009 Oct; 57():722-3. PubMed ID: 20329436
    [No Abstract]   [Full Text] [Related]  

  • 2. [What role for fluoroquinolones in intensive therapy?].
    Viale P; Pea F
    J Chemother; 2003 Aug; 15 Suppl 1():5-10. PubMed ID: 14535066
    [No Abstract]   [Full Text] [Related]  

  • 3. Optimal use of fluoroquinolones in the intensive care unit setting.
    Rotschafer JC; Ullman MA; Sullivan CJ
    Crit Care Clin; 2011 Jan; 27(1):95-106. PubMed ID: 21144988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical pharmacokinetics/pharmacodynamics study on pazufloxacin methanesulphonate injection].
    Wang XG; Miao J; Liang DR; Yu Q; Liang MZ; Zhang SH
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 40(4):689-93. PubMed ID: 19764574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo activities of DW-224a, a novel fluoroquinolone antibiotic agent.
    Kwon AR; Min YH; Ryu JM; Choi DR; Shim MJ; Choi EC
    J Antimicrob Chemother; 2006 Sep; 58(3):684-8. PubMed ID: 16873394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal sepsis in hospital-born babies.
    Butt T; Ahmad RN; Usman M
    J Coll Physicians Surg Pak; 2004 Feb; 14(2):125; author reply 125-6. PubMed ID: 15228882
    [No Abstract]   [Full Text] [Related]  

  • 7. Antimicrobial resistance in Europe and its potential impact on empirical therapy.
    Rossolini GM; Mantengoli E
    Clin Microbiol Infect; 2008 Dec; 14 Suppl 6():2-8. PubMed ID: 19040461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re: Acute bacterial prostatitis in Korea.
    Etienne M; Caron F
    Int J Antimicrob Agents; 2009 Aug; 34(2):185-6. PubMed ID: 19342203
    [No Abstract]   [Full Text] [Related]  

  • 9. Current challenges in the treatment of complicated urinary tract infections and prostatitis.
    Wagenlehner FM; Naber KG
    Clin Microbiol Infect; 2006 May; 12 Suppl 3():67-80. PubMed ID: 16669930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anaerobes: antibiotic resistance, clinical significance, and the role of susceptibility testing.
    Hecht DW
    Anaerobe; 2006 Jun; 12(3):115-21. PubMed ID: 16765857
    [No Abstract]   [Full Text] [Related]  

  • 11. [Fluoroquinolones in ophthalmology: indications and current use].
    Chiquet C; Labetoulle M
    J Fr Ophtalmol; 2008 Oct; 31(8):803-8. PubMed ID: 19107048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors and etiology of neonatal sepsis in Tikur Anbessa University Hospital, Ethiopia.
    Shitaye D; Asrat D; Woldeamanuel Y; Worku B
    Ethiop Med J; 2010 Jan; 48(1):11-21. PubMed ID: 20607993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linezolid resistant enterococcus faecium.
    McNicholas S; Hanahoe B; Higgins F; McAnena O; Corbett-Feeney G; Cormican M
    Ir Med J; 2008; 101(7):225-6. PubMed ID: 18810787
    [No Abstract]   [Full Text] [Related]  

  • 14. [Resistance of causative agents of uncomplicated urinary tract infections in Russia].
    Rafal'skiĭ VV; Strachunskiĭ LS; Babkin PA; Valenskaia VS; Gabbasova LA; Dmitrieva OB; Emel'ianova IV; Krupin VN; Malev IV; Petrov SB; Rokhlikov IM; Furletova NM; Khaĭrullov AS
    Urologiia; 2006; (5):34-7. PubMed ID: 17444150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fluoroquinolones in ophthalmology: mechanisms of action and resistance].
    Labetoulle M; Chiquet C
    J Fr Ophtalmol; 2008 Oct; 31(8):795-801. PubMed ID: 19107047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Moxifloxacin--a novel antimicrobial preparation for treatment of respiratory infections].
    Iakovlev SV; Polushkina NR; Iakovlev VP
    Ter Arkh; 2001; 73(11):15-22. PubMed ID: 11806197
    [No Abstract]   [Full Text] [Related]  

  • 17. Investigation of the susceptibility trends in Japan to fluoroquinolones and other antimicrobial agents in a nationwide collection of clinical isolates: a longitudinal analysis from 1994 to 2002.
    Yamaguchi K; Ohno A;
    Diagn Microbiol Infect Dis; 2005 Jun; 52(2):135-43. PubMed ID: 15964502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New fluoroquinolones: levofloxacin, moxifloxacin and gatifloxacin].
    van der Eerden MM; Boersma WG
    Ned Tijdschr Geneeskd; 2005 Jan; 149(2):109-10; author reply 110. PubMed ID: 15688848
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term trends in the epidemiology of neonatal sepsis and antibiotic susceptibility of causative agents.
    van den Hoogen A; Gerards LJ; Verboon-Maciolek MA; Fleer A; Krediet TG
    Neonatology; 2010; 97(1):22-8. PubMed ID: 19571584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diabetic foot infections. Prevalence and antibiotic sensitivity of the causative microorganisms].
    Martínez-Gómez Dde A; Ramírez-Almagro C; Campillo-Soto A; Morales-Cuenca G; Pagán-Ortiz J; Aguayo-Albasini JL
    Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):317-21. PubMed ID: 19237227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.